Cargando…
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk
Gamma-glutamyltransferase (GGT) is a well-established serum marker for alcohol-related liver disease. However, GGT's predictive utility applies well beyond liver disease: elevated GGT is linked to increased risk to a multitude of diseases and conditions, including cardiovascular disease, diabet...
Autores principales: | Koenig, Gerald, Seneff, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620378/ https://www.ncbi.nlm.nih.gov/pubmed/26543300 http://dx.doi.org/10.1155/2015/818570 |
Ejemplares similares
-
Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016) -
Gamma glutamyltransferase and risk of dementia in prediabetes and diabetes
por: Han, Eugene, et al.
Publicado: (2020) -
Genetically elevated gamma-glutamyltransferase and Alzheimer's disease
por: Kunutsor, Setor K., et al.
Publicado: (2018) -
Serum gamma-glutamyltransferase activity and Parkinson’s disease risk in men and women
por: Yoo, Dallah, et al.
Publicado: (2020) -
Serum Gamma-glutamyltransferase and Obesity: is there a Link?
por: Coku, Viko, et al.
Publicado: (2018)